Epicore Biosystems Secures $26M Funding to Expand Sweat-Sensing Wearable Technology

# Epicore Biosystems Secures $26M Funding to Expand Sweat-Sensing Wearable Technology

Epicore Biosystems, a pioneering company in the field of wearable health monitoring, has successfully secured $26 million in Series B funding. This investment will accelerate the development and commercialization of its innovative sweat-sensing wearable technology, which provides real-time insights into hydration, electrolyte levels, and overall health.

## **Revolutionizing Wearable Health Monitoring**

Founded in 2017 as a spin-off from Northwestern University, Epicore Biosystems specializes in microfluidic-based wearable sensors that analyze sweat composition. Unlike traditional health wearables that primarily track heart rate and movement, Epicore’s technology focuses on sweat biomarkers to provide a deeper understanding of an individual’s hydration status, stress levels, and metabolic health.

The company’s flagship product, the **Connected Hydration™** wearable, is designed to help athletes, military personnel, and industrial workers monitor their hydration needs in real-time. By continuously analyzing sweat, the device provides actionable insights that can prevent dehydration, heat exhaustion, and performance decline.

## **Series B Funding and Growth Plans**

The $26 million Series B funding round was led by **Chevron Technology Ventures, Alumni Ventures, and other strategic investors**. This investment will enable Epicore Biosystems to:

– **Expand Product Development** – Enhance existing wearable technology and develop new applications for broader consumer and medical use.
– **Scale Manufacturing** – Increase production capacity to meet growing demand from sports, military, and industrial sectors.
– **Advance Research & Partnerships** – Collaborate with healthcare institutions, sports organizations, and corporate wellness programs to integrate sweat-based health monitoring into everyday life.

## **The Growing Market for Sweat-Sensing Wearables**

The global wearable health technology market is rapidly expanding, with increasing demand for non-invasive monitoring solutions. Sweat analysis is emerging as a critical tool for personalized health tracking, offering advantages over traditional blood tests and invasive monitoring methods.

Epicore’s technology has already been adopted by professional sports teams, military organizations, and industrial safety programs. By providing real-time hydration and electrolyte data, the company aims to reduce the risks associated with dehydration and heat-related illnesses, which are major concerns in high-performance and extreme environments.

## **Future Implications and Industry Impact**

With this new funding, Epicore Biosystems is well-positioned to lead the next wave of innovation in wearable health technology. The company’s sweat-sensing wearables have the potential to revolutionize personal health monitoring, workplace safety, and athletic performance optimization.

As the demand for real-time, non-invasive health tracking continues to grow, Epicore’s advancements in sweat analysis could pave the way for broader applications in chronic disease management, fitness optimization, and even early disease detection.

### **Conclusion**

Epicore Biosystems’ $26 million funding round marks a significant milestone in the evolution of wearable health technology. By leveraging sweat analysis, the company is unlocking new possibilities for real-time health monitoring, hydration management, and performance enhancement. As it continues to expand its product offerings and market reach, Epicore is set to play a crucial role in shaping the future of personalized health and wellness.